Phospho-Tau (Ser202) Antibody

About the Target

Tau is a well-characterized microtubule-associated protein predominantly expressed in neurons. Under pathological conditions, tau undergoes abnormal aggregation into insoluble fibrils, a process that contributes to synaptic impairment and neuronal death in a group of neurodegenerative disorders collectively known as tauopathies. The human MAPT gene, located on chromosome 17, encodes tau. Depending on the literature source, TAU may also be discussed as Phospho-Tau (Ser202) and Microtubule-associated protein tau.

Reported cellular context includes cell membrane, cell projection, cytoplasm, and cytoskeleton, which can matter when signal is compared across treatments or changing cell states. Following TAU across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

TAU is commonly interpreted in the context of neuroscience research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane, cell projection, and cytoplasm, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cell membrane, cell projection, and cytoplasm across matched conditions
• compartment-specific patterns relevant to neuronal polarity, transport, or synaptic context
• differences between total target abundance and site-specific regulation when modified forms are compared
• co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for TAU. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in TAU reflect biology rather than handling. When interpreting TAU, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep TAU trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.